HGSI Related Rumors

Jul 16, 2012 06:37 AM Human Genome Sciences (HGSI) Agrees to $14/Share Takeover from GSK (GSK) - Reports

Jul 9, 2012 08:44 AM A Celgene (CELG) / Human Genome Sciences (HGSI) Deal Seen as Unlikely

Jun 29, 2012 06:59 AM Human Genome (HGSI) Could Get 15% More in Takeover Bid - Analyst

Jun 15, 2012 08:19 AM Is Human Genome (HGSI) Getting Desperate for a Deal?

Jun 12, 2012 08:31 AM BioMarin (BMRN) Higher as Takeover Chatter Swirls

May 30, 2012 10:19 AM Human Genome (HGSI) Shares Moving as Reuters Says Glaxo (GSK) Wants to Replace Entire Board

May 17, 2012 07:06 AM Human Genome Sciences (HGSI) Unanimously Rejects GlaxoSmithKline (GSK) Offer

May 9, 2012 06:52 AM GlaxoSmithKline (GSK) Commence $13/Share Tender Offer for Human Genome Sciences (HGSI)

Apr 19, 2012 08:06 AM Glaxo's Bid for Human Genome Is a Positive for Anthera Pharma (ANTH) - Analyst

Apr 19, 2012 07:14 AM Human Genome (HGSI) Trades Well Above GSK Offer, Other Biotechs See Action

Apr 12, 2012 11:10 AM UPDATE - UBS Initiates Coverage on Human Genome (HGSI) with a Neutral; See Stock Range-Bound as GSK Hovers

Jan 9, 2012 12:06 AM Bristol-Myers's (BMY) Inhibitex (INHX) Takeover Puts Hep-C, Other Biotechs on M&A Watch

Jan 6, 2012 11:15 AM Owning Biotech Launch Stocks Is One Strategy To Capture Upside - Goldman Sachs

Jan 6, 2012 10:24 AM Human Genome Sciences (HGSI) Gets a Pop On Takeover Rumors

Dec 15, 2011 11:41 AM Biotech M&A Will Be In Focus in 2012 - Goldman

Oct 18, 2011 12:33 PM Piper Jaffray Sees Human Genome (HGSI) Selling for $21-$26/Share in Takeover

Oct 18, 2011 08:11 AM Glaxo (GSK) Could Bid $25/Share for Human Genome (HGSI) -UK's Mail

Mar 29, 2011 05:46 PM Biotech Stocks Could See Action On Valeant (VRX) Bid for Cephalon (CEPH): (BIIB) (JAZZ) (DNDN) (REGN) (more...)

Nov 11, 2010 05:52 PM Human Genome (HGSI) Could Become Takeover Target Upon Approval of Benlysta

Aug 2, 2010 03:48 PM Wall Street Hubbub 8/2: HGSI and MJN Seen As Targets, Layoffs at Barclays?, Goldman Sachs Ticks Off New Neighbors

Jul 12, 2010 12:14 PM Leerink Swann Says M&A Is One Reason To Get Involved In Biophama (AGN, DNDN, BMRN, HGSI, more...)

Jul 7, 2010 09:59 AM Human Genome Sciences (HGSI) Sees Upside

Mar 12, 2010 08:36 AM Piper Jaffray Assumes Coverage on Human Genome Sciences (HGSI) with an Overweight; Benlysta's First Mover Advantage Key to $4bn+ Opportunity

Mar 10, 2010 08:53 AM 'Takeover Fever' Continues In Biotech After Facet (FACT) Deal, Who's Next?

Mar 1, 2010 09:43 AM Biotech Rumor Mill Hopping After Hostile Bid for OSI Pharmaceuticals (OSIP)

Nov 3, 2009 10:28 AM Goldman Sachs Lifts Tgt on Human Genome Sciences (HGSI) to $30, Sees As Acquisition Candidate

Oct 15, 2009 06:56 AM Goldman Sachs Resumes Human Genome Sciences (HGSI) at Buy, Sees As Potential Takeover Target

Sep 22, 2009 01:02 PM Biotech Takeover Buzz Continues (VVUS, DNDN, HGSI, IMMU, CEPH)

Sep 18, 2009 01:46 PM Human Genome (HGSI) Up On More Takeover Talk

Sep 14, 2009 03:32 PM PDL BioPharma (PDLI) Thrown Into Biotech Rumor Mill Today

Sep 14, 2009 03:19 PM Human Genome Sciences (HGSI) Climbs Higher On Takeover Speculation

Aug 25, 2009 11:59 AM Human Genome (HGSI) Shares Spike as GlaxoSmithKline (GSK) Rumored to Have $30/Share Bid Ready

Jul 16, 2009 01:31 PM Human Genome Sciences (HGSI) Surges Higher Ahead of Benlysta Data

Apr 23, 2007 11:21 AM Rodman & Renshaw Comments on the "Aftershock" of MEDI/AZN Deal

Jun 8, 2006 12:19 AM Citigroup Addresses Concerns on Human Genome Sciences (HGSI)